UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
zibotentan (37) 37
science & technology (31) 31
life sciences & biomedicine (29) 29
humans (25) 25
male (21) 21
cancer (16) 16
pharmacology & pharmacy (16) 16
prostate cancer (15) 15
pyrrolidines - administration & dosage (13) 13
endothelin a receptor antagonists (12) 12
pyrrolidines - adverse effects (12) 12
care and treatment (11) 11
endothelin (11) 11
middle aged (11) 11
prostatic neoplasms - drug therapy (11) 11
aged (10) 10
oncology (10) 10
pyrrolidines - therapeutic use (9) 9
animals (8) 8
antineoplastic agents - therapeutic use (8) 8
pyrrolidines - pharmacokinetics (8) 8
research (8) 8
treatment outcome (8) 8
antineoplastic agents - adverse effects (7) 7
female (7) 7
aged, 80 and over (6) 6
analysis (6) 6
atrasentan (6) 6
bone neoplasms - secondary (6) 6
medicine & public health (6) 6
metastasis (6) 6
orchiectomy (6) 6
prostatic neoplasms - pathology (6) 6
zd4054 (6) 6
antineoplastic agents - administration & dosage (5) 5
antineoplastic agents - pharmacokinetics (5) 5
bone neoplasms - drug therapy (5) 5
castration-resistant prostate cancer (5) 5
chemotherapy (5) 5
disease-free survival (5) 5
dose-response relationship, drug (5) 5
double-blind method (5) 5
pharmacokinetics (5) 5
pyrrolidines - pharmacology (5) 5
toxicology (5) 5
urology & nephrology (5) 5
adult (4) 4
anticancer properties (4) 4
antineoplastic agents (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
cancer research (4) 4
chemistry (4) 4
clinical trials (4) 4
clinical trials as topic (4) 4
development and progression (4) 4
drug therapy (4) 4
oncology, experimental (4) 4
ovarian cancer (4) 4
pharmacology/toxicology (4) 4
adenocarcinoma - drug therapy (3) 3
administration, oral (3) 3
antimitotic agents (3) 3
antineoplastic agents - pharmacology (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
cancer patients (3) 3
complications and side effects (3) 3
drug administration schedule (3) 3
drug therapy, combination (3) 3
endothelin receptor (3) 3
et-1 (3) 3
etoposide (3) 3
internal medicine (3) 3
mice (3) 3
neoplasm metastasis (3) 3
neoplasms, glandular and epithelial - drug therapy (3) 3
ovarian neoplasms - drug therapy (3) 3
physical sciences (3) 3
prostatic neoplasms - metabolism (3) 3
prostatic neoplasms - surgery (3) 3
prostatic neoplasms, castration-resistant - drug therapy (3) 3
pyrrolidines - metabolism (3) 3
receptor (3) 3
1,3,4-oxadiazoles (2) 2
antagonist drugs (2) 2
antineoplastic agents - metabolism (2) 2
area under curve (2) 2
asian continental ancestry group (2) 2
bevacizumab (2) 2
biotransformation (2) 2
bone cancer (2) 2
bone neoplasms - metabolism (2) 2
carcinoma, ovarian epithelial (2) 2
cardiovascular system (2) 2
castrate-resistant prostate cancer (2) 2
castration‐resistant prostate cancer (2) 2
chromatography, high pressure liquid (2) 2
combination therapy (2) 2
cytotoxicity (2) 2
derivatives (2) 2
docetaxel (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chemical Data Collections, ISSN 2405-8300, 12/2020, Volume 30
A novel series of 1,3,4-oxadiazole fused tetrazole amide derivatives (11a-j) were designed, synthesized and evaluated for their anticancer activities against... 
TAK-456 and anticancer activity | Losartan | Raltegravir | Zibotentan
Journal Article
Journal Article
Journal Article
Synthetic communications, ISSN 0039-7911, 03/2019, Volume 49, Issue 13, pp. 1603 - 1612
As an aspect of our ongoing research in search of new anticancer agents, a series of novel analogs of 1,3,4-oxadiazole embedded with 1,2,4-oxadiazole moieties... 
phidianidines A | anticancer activity | Raltegravir | Zibotentan | B | Physical Sciences | Chemistry | Chemistry, Organic | Science & Technology | Biotechnology | Synthesis | Nuclear magnetic resonance--NMR | Binding sites | Molecular docking | Cancer | Anticancer properties
Journal Article